BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 8:12:00 PM | Browse: 1076 | Download: 1432
Publication Name World Journal of Medical Genetics
Manuscript ID 4056
Country Japan
Received
2013-06-11 22:47
Peer-Review Started
2013-06-12 19:23
To Make the First Decision
2013-08-08 11:16
Return for Revision
2013-08-08 17:54
Revised
2013-08-29 22:12
Second Decision
2013-09-03 14:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-04 07:22
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-12-03 11:29
Publish the Manuscript Online
2013-12-16 13:25
ISSN 2220-3184 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Autobiography
Article Title Inhibitor of HIF-α subunit expression suppresses hypoxia-induced dedifferentiation of human NSCLC into cancer stem cell-like cells
Manuscript Source Invited Manuscript
All Author List Miho Akimoto, Hideko Nagasawa, Hitoshi Hori, Yoshihiro Uto, Yoshio Honma and Keizo Takenaga
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Education, Culture, Sports, Science and Technology 18590280
Foundation for the Promotion of Cancer Research in Japan
Japan Arteriosclerosis Research Foundation
Shimane University “S-TAKUMI Medical Nanotechnology” Project
Corresponding Author Keizo Takenaga, PhD, Associated professor, Department of Life Science, Shimane University Faculty of Medicine, 89-1 Enya, Izumo 693-8501, Japan. biokeizo@med.shimane-u.ac.jp
Key Words Non-small cell lung cancer; Tumor microenvironment; Hypoxia; Hypoxia-inducible factor; Differentiation; Cancer stem cells; Hypoxia-inducible factor inhibitor
Core Tip Hypoxia induces the de-differentiation of human non-small cell lung cancer cells into cancer stem cell-like cells, and TX-402, a small-molecule inhibitor of hypoxia-inducible factor (HIF)-1α and HIF-2α expression, suppresses this hypoxia-induced process and, importantly, the metastatic ability of the cells.
Publish Date 2013-12-16 13:25
Citation Akimoto M, Nagasawa H, Hori H, Uto Y, Honma Y, Takenaga K. An inhibitor of HIF-α subunit expression suppresses hypoxia-induced dedifferentiation of human NSCLC into cancer stem cell-like cells. World J Med Genet 2013; 3(4): 41-54
URL http://www.wjgnet.com/2220-3184/full/v3/i4/41.htm
DOI http://dx.doi.org/10.5496/wjmg.v3.i4.41
Full Article (PDF) WJMG-3-41.pdf
Full Article (Word) WJMG-3-41.doc
Manuscript File 4056-Review.doc
Answering Reviewers 4056-Answering reviewers.pdf
Copyright License Agreement 4056-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 4056-Language certification.pdf
Peer-review Report 4056-Peer review(s).pdf
Scientific Editor Work List 4056-Scientific editor work list.doc